Other

Eli Lilly to acquire Loxo Oncology for $8 billion

Pharmaceutical giant Eli Lilly announced Monday it will acquire Loxo Oncology for around $8 billion, the latest big transaction aimed at developing and monetizing new treatments for cancer.

Alzheimer's disease & dementia

UK, US drugmakers scrap 'futile' Alzheimer's treatment trial

British and American pharmaceutical giants AstraZeneca and Eli Lilly on Tuesday said they were ending a large clinical trial of a treatment for Alzheimer's that they had been developing jointly.

page 1 from 8